Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Economic impact of musculoskeletal disorders (MSDs) on work in Europe
AU - Bevan, Stephen Mark
PY - 2015/6
Y1 - 2015/6
N2 - Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, ‘presenteeism’ and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs.
AB - Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, ‘presenteeism’ and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs.
KW - Musculoskeletal
KW - Productivity
KW - Employment
KW - Sickness absence
KW - Work disability
KW - Early intervention
KW - European Union
U2 - 10.1016/j.berh.2015.08.002
DO - 10.1016/j.berh.2015.08.002
M3 - Journal article
VL - 29
SP - 356
EP - 373
JO - Best Practice and Research Clinical Rheumatology
JF - Best Practice and Research Clinical Rheumatology
SN - 1521-6942
IS - 3
ER -